ReviewRenal failure2026
Protecting peritoneal dialysis patients: evaluation and prevention strategies for noninfectious risk factors.
Review in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Noninfectious risk factors in peritoneal dialysis (PD) are often overlooked, yet they significantly worsen patient outcomes. This review highlights nine key risk factors: advanced age and psychosocial vulnerability, malnutrition and sarcopenia, glucose and lipid metabolism disorders, hypoalbuminemia, chronic microinflammation, gut dysbiosis, kidney anemia, chronic kidney disease-mineral and bone disorder, and volume overload with elevated intra-abdominal pressure. These factors interact to increase the risks of death, decline of residual kidney function, peritoneal fibrosis and cardiovascular events. We outline practical, evidence-based protective strategies that integrate nutritional and physical rehabilitation, biocompatible dialysis regimens, individualized fluid and dialysis prescription, targeted pharmacotherapy, psychosocial support, and regular monitoring of integrated inflammatory and nutritional biomarkers. The goal is to help clinicians improve long-term outcomes and quality of life for PD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.